RPT-ZELGEN BIOPHARMA <688266.SS> SAYS IT SIGNS STRATEGIC PARTNERSHIP WITH ABBVIE FOR DEVELOPMENT AND COMMERCIALISATION OF ALVELTAMIG

Reuters · 12/31/2025 09:42

Please log in to view news